Final Products
    Intermediates of Larotrectinib(LOXO-101)
    Intermediates of Ivabradine
    Intermediates of Dacomitinib
    Intermediates of Efinaconazole
    Intermediates of Olodaterol
    Intermediates of Ticagrelor
    Intermediates of Entrectinib
    Intermediates of Acotiamide
    Intermediates of Dofetilide
    Piperazine derivative
    Piperidine derivative
    Pyrrolidine derivative
    Pyridine derivative
    Other Intermediates
    Intermediates of Mirabegron
    Intermediates of Tiotropium Bromide
    Intermediates of Vilanterol
    Intermediates of Umeclidinium bromide
    Intermediates of Glycopyrrolate Bromide
    Intermediates of Donepezil HCI
      News Center


    Nanchang helioeast pharmaceutical limited company visited our company and signed a project cooperation agreement

    In September 10th, Nanchang helioeast Pharmaceutical Co. Ltd. visited our company with the leader of R & D, technology, production and quality department , and communicated in-depth in cooperation projects.

    Company chairman Xu Kun briefed the guests on the basic situation of details of the company and later on R & D, production, project development plan, and lead the guests to the company in the production factory, research and development center, analysis center, safety and environmental protection facilities and the two phase of the project was to visit. Nanchang Hongyi pharmaceutical leaders highly affirmed on the company's development situation and planning, scientific research strength, safety and environmental protection measures.The leader of company R & D, technology, quality, production department and other people attended the reception and talks.

    Both sides have fully communicated and signed a cooperation agreement for the in-depth cooperation between the previous project and the follow-up project.



    Copyright(C)2017 , Jinan Dexinjia Bio&Tech Co.,Ltd. All Rights Reserved.  Supported by  ChemNet  ChinaChemNet Toocle Copyright Notice